arrow
P

Pamela Krueger

Regeneron
H指数:9
被引数:870

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Effects of Fasinumab on Peripheral Nerve Function and Ganglion Anatomy: Results From a Randomized, Double-Blind, Placebo-Controlled Study in Patients With Pain Due to Osteoarthritis of the Knee or Hip, and a Series of Nonclinical Studies

fasinumab对周围神经功能及神经节解剖结构的影响:来自一项在因膝或髋关节骨关节炎疼痛患者中进行的随机、双盲、安慰剂对照研究以及一系列非临床研究的成果

2025-11-010
OAAI
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Ra strengthens T cell-mediated anti-tumor therapies
2024-10-010
OAAI
REGN10597: A PD-1-targeted, receptor-masked wild type IL-2 with improved therapeutic window for cancer immunotherapy
2023-12-010
PRE
A PD-1-targeted, receptor-masked IL-2 immunocytokine with maintained potential to engage endogenous IL-2Ra drives selective stimulation of PD-1+ T cells and robust anti-tumor efficacy
2023-04-041
PRE
A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade
2021-07-2629
OAAI
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy
2020-06-2466
PREAI
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties
2019-12-264
OAAI
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer
2019-06-19100
OAAI
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
2014-03-25437
OA